Published in Pharmacol Biochem Behav on May 01, 1980
Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev (2007) 6.36
Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology (2008) 2.80
Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) (2003) 2.27
The neurocircuitry of addiction: an overview. Br J Pharmacol (2008) 2.11
Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci (2011) 2.05
Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci (2006) 2.03
The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol Psychiatry (2007) 1.89
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord (2012) 1.73
Administration of the D1-like dopamine receptor antagonist SCH-23390 into the medial nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug-seeking behavior in rats. Psychopharmacology (Berl) (2002) 1.65
Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration. Learn Mem (2004) 1.63
Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci Biobehav Rev (2010) 1.57
Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Psychopharmacology (Berl) (2004) 1.47
Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. Curr Top Behav Neurosci (2010) 1.46
A shift in the role of glutamatergic signaling in the nucleus accumbens core with the development of an addicted phenotype. Biol Psychiatry (2014) 1.45
Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. Eur J Neurosci (2005) 1.37
Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Biobehav Rev (2009) 1.31
Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. J Pharmacol Exp Ther (2009) 1.27
Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference. Neuropsychopharmacology (2009) 1.22
Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.19
Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food. J Exp Anal Behav (1994) 1.10
Biological mechanisms underlying the relationship between stress and smoking: state of the science and directions for future work. Biol Psychol (2011) 1.09
Extracellular fluctuations of dopamine and glutamate in the nucleus accumbens core and shell associated with lever-pressing during cocaine self-administration, extinction, and yoked cocaine administration. Psychopharmacology (Berl) (2010) 1.08
Phenotypic insights into ADCY5-associated disease. Mov Disord (2016) 1.06
The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors. Prog Neurobiol (2015) 1.06
Cocaine disinhibits dopamine neurons in the ventral tegmental area via use-dependent blockade of GABA neuron voltage-sensitive sodium channels. Eur J Neurosci (2008) 1.04
Patterns of functional activity associated with cocaine self-administration in the rat change over time. Psychopharmacology (Berl) (2003) 1.04
κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake. J Neurosci (2015) 1.03
Individual variation in the motivational and neurobiological effects of an opioid cue. Neuropsychopharmacology (2015) 1.03
A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats. Psychopharmacology (Berl) (2012) 1.01
Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats. Br J Pharmacol (2014) 0.99
Slow phasic and tonic activity of ventral pallidal neurons during cocaine self-administration. Synapse (2011) 0.99
Rapid phasic activity of ventral pallidal neurons during cocaine self-administration. Synapse (2010) 0.96
Distinct contributions of dopamine in the dorsolateral striatum and nucleus accumbens shell to the reinforcing properties of cocaine. Neuropsychopharmacology (2011) 0.95
Reward, interrupted: Inhibitory control and its relevance to addictions. Neuropharmacology (2013) 0.94
Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence. Curr Drug Targets (2013) 0.94
Differentiating the rapid actions of cocaine. Nat Rev Neurosci (2011) 0.92
Basal ganglia circuit loops, dopamine and motivation: A review and enquiry. Behav Brain Res (2015) 0.90
Loss of functional specificity in the dorsal striatum of chronic cocaine users. Drug Alcohol Depend (2009) 0.90
The avian subpallium: new insights into structural and functional subdivisions occupying the lateral subpallial wall and their embryological origins. Brain Res (2011) 0.89
Histamine and motivation. Front Syst Neurosci (2012) 0.89
Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation. J Pharmacol Exp Ther (2009) 0.89
Amphetamine potency varies with dopamine uptake rate across striatal subregions. J Neurochem (2014) 0.87
Lack of cocaine-like discriminative-stimulus effects of σ-receptor agonists in rats. Behav Pharmacol (2011) 0.87
Effects of SCH 23390 and eticlopride on cocaine-seeking produced by cocaine and WIN 35,428 in rats. Psychopharmacology (Berl) (2002) 0.86
A single high dose of methamphetamine increases cocaine self-administration by depletion of striatal dopamine in rats. Neuroscience (2009) 0.85
Adaptations of presynaptic dopamine terminals induced by psychostimulant self-administration. ACS Chem Neurosci (2014) 0.85
Transdermal selegiline and intravenous cocaine: safety and interactions. Psychopharmacology (Berl) (2003) 0.84
Systems level neuroplasticity in drug addiction. Cold Spring Harb Perspect Med (2013) 0.83
Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains. Exp Clin Psychopharmacol (2011) 0.82
Prior extended daily access to cocaine elevates the reward threshold in a conditioned place preference test. Addict Biol (2013) 0.82
Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects. Psychopharmacology (Berl) (2004) 0.81
Cocaine-seeking behavior after extended cocaine-free periods in rats: role of conditioned stimuli. Psychopharmacology (Berl) (2002) 0.81
Lesions and reversible inactivation of the dorsolateral caudate-putamen impair cocaine-primed reinstatement to cocaine-seeking in rats. Brain Res (2011) 0.81
Presynaptic dopamine modulation by stimulant self-administration. Front Biosci (Schol Ed) (2013) 0.81
Performance on an impulse control task is altered in adult rats exposed to amphetamine during adolescence. Dev Psychobiol (2012) 0.81
DREADD-Induced Silencing of the Medial Olfactory Tubercle Disrupts the Preference of Female Mice for Opposite-Sex Chemosignals(1,2,3). eNeuro (2015) 0.80
New medications for the treatment of cocaine dependence. Psychiatry (Edgmont) (2005) 0.80
Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine. Eur J Neurosci (2015) 0.80
Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding. J Neuroimmune Pharmacol (2015) 0.79
The effects of medial prefrontal cortex infusions of cocaine in a runway model of drug self-administration: evidence of reinforcing but not anxiogenic actions. Eur J Pharmacol (2009) 0.79
Group II metabotropic glutamate receptors in the striatum of non-human primates: dysregulation following chronic cocaine self-administration. Neurosci Lett (2011) 0.79
In vivo analysis of the role of dopamine in stimulant and opiate self-administration. J Psychiatry Neurosci (1996) 0.78
Effects of inhibitory GABA-active neurosteroids on cocaine seeking and cocaine taking in rats. Psychopharmacology (Berl) (2014) 0.78
Effects of dopamine D(2)-like receptor agonists in mice trained to discriminate cocaine from saline: influence of feeding condition. Eur J Pharmacol (2014) 0.77
Time-dependent recovery from the effects of 6-hydroxydopamine lesions of the rat nucleus accumbens on cocaine self-administration and the levels of dopamine in microdialysates. Psychopharmacology (Berl) (2003) 0.76
Cocaine-Induced Synaptic Alterations in Thalamus to Nucleus Accumbens Projection. Neuropsychopharmacology (2016) 0.76
Chronic dopamine antagonism facilitates opiate-induced feeding. J Psychiatry Neurosci (1995) 0.75
Abundant collateralization of temporal lobe projections to the accumbens, bed nucleus of stria terminalis, central amygdala and lateral septum. Brain Struct Funct (2016) 0.75
Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods (1996) 6.41
Transition from moderate to excessive drug intake: change in hedonic set point. Science (1998) 5.66
Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem (1975) 3.97
Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science (1993) 3.67
Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res (2000) 3.33
Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry (1995) 3.30
Dramatic decreases in brain reward function during nicotine withdrawal. Nature (1998) 3.21
Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology (2000) 3.15
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron (1998) 3.08
Suppression of psychoactive effects of cocaine by active immunization. Nature (1995) 3.05
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet (2000) 3.04
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology (1998) 2.96
Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend (1998) 2.94
Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther (1993) 2.79
Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci (1995) 2.70
Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res (1998) 2.60
Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res (1996) 2.51
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science (1997) 2.50
Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology (1991) 2.41
Animal models of drug craving. Psychopharmacology (Berl) (1993) 2.32
A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav (1997) 2.28
Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res (1993) 2.27
Cocaine vaccines: antibody protection against relapse in a rat model. Proc Natl Acad Sci U S A (2000) 2.16
Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) (1984) 2.13
On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav (1977) 2.11
Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell (1994) 2.05
Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology (2000) 2.04
CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl) (1991) 2.04
Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology (Berl) (1999) 2.01
Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci U S A (1995) 2.00
Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav (1992) 1.96
Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci (1996) 1.95
GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur J Pharmacol (1995) 1.93
Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (1996) 1.91
Corticotropin releasing factor produces behavioural activation in rats. Nature (1982) 1.82
A second-generation vaccine protects against the psychoactive effects of cocaine. Proc Natl Acad Sci U S A (2001) 1.78
Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci (2001) 1.78
Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology (Berl) (1982) 1.76
mu-Opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther (2000) 1.67
Performance norms for a rhesus monkey neuropsychological testing battery: acquisition and long-term performance. Brain Res Cogn Brain Res (1999) 1.66
Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci (1994) 1.65
Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study. Neurology (1973) 1.62
Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci (1994) 1.61
Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. J Neurosci (1992) 1.60
Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res (1992) 1.60
Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res (1995) 1.59
Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav (1999) 1.58
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci (1982) 1.57
Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther (2000) 1.56
Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: a retro- and antero-grade transport and immunohistochemical study. J Comp Neurol (1992) 1.54
Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment. J Neurosci (1995) 1.53
Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology (Berl) (1997) 1.50
Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology (Berl) (1987) 1.49
Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther (1994) 1.47
Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res (1982) 1.47
Dietary treatment of iron deficiency in women of childbearing age. Am J Clin Nutr (2001) 1.47
Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) (1999) 1.46
Operant self-administration of sweetened versus unsweetened ethanol: effects on blood alcohol levels. Alcohol Clin Exp Res (1999) 1.45
Transient torsion during and after saccades. Vision Res (1995) 1.45
Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem (2000) 1.44
Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology (1993) 1.43
Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science (1993) 1.43
Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav (1982) 1.41
Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology (Berl) (1986) 1.38
Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology (Berl) (1992) 1.38
Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear. J Neurosci (1996) 1.38
Drugs of abuse and the brain. Proc Assoc Am Physicians (1999) 1.35
Time-dependent quantifiable withdrawal from ethanol in the rat: effect of method of dependence induction. Alcohol (1996) 1.35
Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res (1992) 1.35
Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res (1982) 1.35
Ontogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat. Science (1969) 1.35
Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther (1994) 1.35
The nucleus basalis magnocellularis: the origin of a cholinergic projection to the neocortex of the rat. Neuroscience (1980) 1.34
Conditioned defensive burying: a new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav (1981) 1.31
Dopaminergic correlates of motivated behavior: importance of drive. J Neurosci (1995) 1.29
Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther (1992) 1.29
Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res (2001) 1.29
Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats. Ann N Y Acad Sci (2003) 1.28
Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience (1990) 1.28
The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res (1982) 1.26
Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm. Alcohol Clin Exp Res (1997) 1.26
Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience (1992) 1.26
Body weight and dietary factors in Huntington's disease patients compared with matched controls. Med J Aust (1981) 1.26
Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol (1994) 1.26
NADPH-diaphorase: a selective histochemical marker for the cholinergic neurons of the pontine reticular formation. Neurosci Lett (1983) 1.24
Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Australian women of childbearing age. J Am Coll Nutr (2001) 1.24
Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther (1994) 1.23
Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther (1988) 1.23
D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience (1992) 1.23
Attenuation by haloperidol of place preference conditioning using food reinforcement. Psychopharmacology (Berl) (1982) 1.22
Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J Neurosci (1995) 1.19
Cholinergic neurons of the laterodorsal tegmental nucleus: efferent and afferent connections. J Comp Neurol (1986) 1.18
Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology (1989) 1.18
Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology (Berl) (2000) 1.18
Low-glycemic index foods improve long-term glycemic control in NIDDM. Diabetes Care (1991) 1.17
Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J Neurochem (1995) 1.17
Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women's Health. Qual Life Res (2000) 1.17